| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.17B | 1.27B | 1.34B | 932.64M | 534.82M | 499.63M |
| Gross Profit | 720.59M | 756.21M | 112.62M | 588.60M | 322.54M | 303.12M |
| EBITDA | 557.59M | 755.66M | 780.51M | 555.62M | 287.60M | 274.18M |
| Net Income | -368.22M | -654.49M | -278.26M | -106.00M | 14.32M | 19.19M |
Balance Sheet | ||||||
| Total Assets | 9.86B | 10.65B | 12.64B | 13.85B | 4.26B | 3.81B |
| Cash, Cash Equivalents and Short-Term Investments | 43.34M | 68.92M | 25.70M | 60.96M | 13.18M | 15.30M |
| Total Debt | 238.88M | 4.96B | 5.30B | 5.70B | 1.92B | 1.71B |
| Total Liabilities | 5.11B | 5.35B | 5.71B | 6.17B | 2.07B | 1.86B |
| Stockholders Equity | 4.68B | 5.23B | 6.82B | 7.57B | 2.19B | 1.95B |
Cash Flow | ||||||
| Free Cash Flow | 400.53M | 252.64M | 268.79M | 109.20M | 131.94M | 376.13M |
| Operating Cash Flow | 462.77M | 501.62M | 499.82M | 272.75M | 232.63M | 470.09M |
| Investing Cash Flow | 603.12M | 900.92M | 349.14M | 1.63B | -562.47M | -555.17M |
| Financing Cash Flow | -1.05B | -1.36B | -884.22M | -1.86B | 327.72M | 99.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $7.94B | 26.50 | 8.13% | 3.58% | 59.25% | 88.37% | |
75 Outperform | $3.58B | 24.05 | 10.87% | 4.81% | 8.04% | 9.20% | |
74 Outperform | $4.70B | 25.92 | 6.29% | 6.59% | 8.12% | 75.95% | |
70 Neutral | $8.17B | 340.34 | 1.12% | 2.02% | 11.80% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
57 Neutral | $6.30B | ― | -7.26% | 6.59% | -6.59% | 33.35% | |
54 Neutral | $3.03B | ― | -14.02% | 6.31% | 45.56% | 73.44% |
Healthcare Realty Trust Incorporated’s recent earnings call exuded a positive sentiment, driven by strong NOI growth, improved occupancy rates, and significant asset dispositions. The company showcased effective leverage management and capital readiness for growth opportunities, though challenges persist in non-core markets, indicating ongoing restructuring efforts.
Healthcare Realty Trust reported a GAAP net loss of $0.17 per share for the third quarter of 2025, with Normalized FFO of $0.41 per share and a same-store cash NOI growth of 5.4%, driven by increased occupancy and tenant retention. The company executed leases totaling 1.6 million square feet and completed asset sales worth $404 million, with additional sales under contract, reflecting strategic market exits and property monetizations. The company also advanced its development and redevelopment projects, enhancing its portfolio in key markets. The board approved a dividend of $0.24 per share, and the company increased its guidance for Normalized FFO per share and same-store cash NOI growth for 2025.
The most recent analyst rating on (HR) stock is a Hold with a $18.00 price target. To see the full list of analyst forecasts on Healthcare Realty Trust stock, see the HR Stock Forecast page.